The tariff classification of Carbidopa and Levodopa Extended-Release Capsules in dosage form, from India
Reasoning
The tariff classification of Carbidopa and Levodopa Extended-Release Capsules in dosage form, from India
Cite this ruling
CBP Ruling N351756 (3004909240): The tariff classification of Carbidopa and Levodopa Extended-Release Capsules in dosage form, from India
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300490
The tariff classification of Tolevamer (code designation: GT267-004), imported in bulk form; Tolevamer 7% Oral Solution, imported put up in 45 mL single-use bottles; and Tolevamer 7% Oral Solution Placebo, imported put up in 45 mL single-use bottles, from Ireland and the United Kingdom
The tariff classification of Stryker® TCP Putty from Ireland
The tariff classification of Bortezomib (CAS-179324-69-7), imported in bulk form, and VELCADE® (bortezomib) for Injection, from Canada and the United Kingdom
The tariff classification of BETAGAN® (levobunolol hydrochloride ophthalmic solution, USP) 0.5%, supplied in 10mL and 15mL plastic bottles with dropper tips and screw-down caps.
The tariff classification of OCUFLOX® (ofloxacin ophthalmic solution) 0.3%